Impact of Farnesylation Inhibitors on Survival in Hutchinson-Gilford Progeria Syndrome
- Author
- GORDON, Leslie B1 2 ; MASSARO, Joe3 ; D'AGOSTINO, Ralph B3 ; CAMPBELL, Susan E4 ; BRAZIER, Joan4 ; BROWN, W. Ted5 ; KLEINMAN, Monica E2 ; KIERAN, Mark W6
[1] Department of Pediatrics, Hasbro Children's Hospital and Warren Alpert Medical School of Brown University, Providence, RI, United States
[2] Department of Anesthesia, Division of Critical Care Medicine, Boston Children's Hospital and Harvard Medical School, Boston, MA, United States
[3] Department of Mathematics and Statistics, Boston University, Harvard Clinical Research Institute, Boston, MA, United States
[4] Center for Gerontology and Health Care Research, Brown University, Providence, RI, United States
[5] Department of Genetics, New York State Institute for Basic Research, Staten Island, NY, United States
[6] Hematology-Oncology, Boston Children's Hospital, Division of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, United States
Progeria Clinical Trials Collaborative, United States - Source
Circulation (New York, N.Y.). 2014, Vol 130, Num 1, pp 27-34, 8 p ; ref : 35 ref
- CODEN
- CIRCAZ
- ISSN
- 0009-7322
- Scientific domain
- Cardiology, blood circulation, phlebology
- Publisher
- Lippincott Williams & Wilkins, Hagerstown, MD
- Publication country
- United States
- Document type
- Article
- Language
- English
- Author keyword
- Kaplan-Meier estimate aging atherosclerosis lamins lonafarnib prenylation progeria
- Keyword (fr)
- Anticancéreux Appareil circulatoire Athérosclérose Cardiologie Estimation Inhibiteur Lonafarnib Pathologie de l'appareil circulatoire Progéria Pronostic Survie Syndrome Sénescence Vieillissement Méthode Kaplan-Meier Nanisme Pathologie de la peau Pathologie des vaisseaux sanguins
- Keyword (en)
- Antineoplastic agent Circulatory system Atherosclerosis Cardiology Estimation Inhibitor Lonafarnib Cardiovascular disease Progeria Prognosis Survival Syndrome Senescence Ageing Kaplan-Meier method Dwarfism Skin disease Vascular disease
- Keyword (es)
- Anticanceroso Aparato circulatorio Ateroesclerosis Cardiología Estimación Inhibidor Lonafarnib Aparato circulatorio patología Progería Pronóstico Sobrevivencia Síndrome Senescencia Envejecimiento Enanismo Piel patología Vaso sanguíneo patología
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B12 Cardiology. Vascular system / 002B12B Blood and lymphatic vessels / 002B12B01 Atherosclerosis (general aspects, experimental research)
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B12 Cardiology. Vascular system / 002B12B Blood and lymphatic vessels / 002B12B03 Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous
- Discipline
- Cardiology. Circulatory system
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 28597476
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1161/CIRCULATIONAHA.113.008285 
https://dx.doi.org/10.1161/CIRCULATIONAHA.113.008285
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:33:\"10.1161\/CIRCULATIONAHA.113.008285\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:86:\"Impact of Farnesylation Inhibitors on Survival in Hutchinson-Gilford Progeria Syndrome\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Circulation (New York, N.Y.)\";s:9:\"\u0000*\u0000stitle\";s:24:\"Circulation (N. Y. N.Y.)\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:3:\"130\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"27\";s:8:\"\u0000*\u0000epage\";s:2:\"34\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0009-7322\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"GORDON\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Leslie B\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:12:\"MASSARO, Joe\";i:1;s:19:\"D'AGOSTINO, Ralph B\";i:2;s:17:\"CAMPBELL, Susan E\";i:3;s:13:\"BRAZIER, Joan\";i:4;s:13:\"BROWN, W. Ted\";i:5;s:18:\"KLEINMAN, Monica E\";i:6;s:14:\"KIERAN, Mark W\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CIRCAZ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:86:\"Impact of Farnesylation Inhibitors on Survival in Hutchinson-Gilford Progeria Syndrome\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:33:\"10.1161\/CIRCULATIONAHA.113.008285\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:86:\"Impact of Farnesylation Inhibitors on Survival in Hutchinson-Gilford Progeria Syndrome\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Circulation (New York, N.Y.)\";s:9:\"\u0000*\u0000stitle\";s:24:\"Circulation (N. Y. N.Y.)\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:3:\"130\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"27\";s:8:\"\u0000*\u0000epage\";s:2:\"34\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0009-7322\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"GORDON\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Leslie B\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:12:\"MASSARO, Joe\";i:1;s:19:\"D'AGOSTINO, Ralph B\";i:2;s:17:\"CAMPBELL, Susan E\";i:3;s:13:\"BRAZIER, Joan\";i:4;s:13:\"BROWN, W. Ted\";i:5;s:18:\"KLEINMAN, Monica E\";i:6;s:14:\"KIERAN, Mark W\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CIRCAZ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:86:\"Impact of Farnesylation Inhibitors on Survival in Hutchinson-Gilford Progeria Syndrome\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:33:\"10.1161\/CIRCULATIONAHA.113.008285\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:33:\"10.1161\/CIRCULATIONAHA.113.008285\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:86:\"Impact of Farnesylation Inhibitors on Survival in Hutchinson-Gilford Progeria Syndrome\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Circulation (New York, N.Y.)\";s:9:\"\u0000*\u0000stitle\";s:24:\"Circulation (N. Y. N.Y.)\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:3:\"130\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"27\";s:8:\"\u0000*\u0000epage\";s:2:\"34\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0009-7322\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"GORDON\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Leslie B\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:12:\"MASSARO, Joe\";i:1;s:19:\"D'AGOSTINO, Ralph B\";i:2;s:17:\"CAMPBELL, Susan E\";i:3;s:13:\"BRAZIER, Joan\";i:4;s:13:\"BROWN, W. Ted\";i:5;s:18:\"KLEINMAN, Monica E\";i:6;s:14:\"KIERAN, Mark W\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CIRCAZ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:86:\"Impact of Farnesylation Inhibitors on Survival in Hutchinson-Gilford Progeria Syndrome\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:33:\"10.1161\/CIRCULATIONAHA.113.008285\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:86:\"Impact of Farnesylation Inhibitors on Survival in Hutchinson-Gilford Progeria Syndrome\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Circulation (New York, N.Y.)\";s:9:\"\u0000*\u0000stitle\";s:24:\"Circulation (N. Y. N.Y.)\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:3:\"130\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"27\";s:8:\"\u0000*\u0000epage\";s:2:\"34\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0009-7322\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"GORDON\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Leslie B\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:12:\"MASSARO, Joe\";i:1;s:19:\"D'AGOSTINO, Ralph B\";i:2;s:17:\"CAMPBELL, Susan E\";i:3;s:13:\"BRAZIER, Joan\";i:4;s:13:\"BROWN, W. Ted\";i:5;s:18:\"KLEINMAN, Monica E\";i:6;s:14:\"KIERAN, Mark W\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CIRCAZ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:86:\"Impact of Farnesylation Inhibitors on Survival in Hutchinson-Gilford Progeria Syndrome\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:33:\"10.1161\/CIRCULATIONAHA.113.008285\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:86:\"Impact of Farnesylation Inhibitors on Survival in Hutchinson-Gilford Progeria Syndrome\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Circulation (New York, N.Y.)\";s:9:\"\u0000*\u0000stitle\";s:24:\"Circulation (N. Y. N.Y.)\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:3:\"130\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"27\";s:8:\"\u0000*\u0000epage\";s:2:\"34\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0009-7322\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"GORDON\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Leslie B\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:12:\"MASSARO, Joe\";i:1;s:19:\"D'AGOSTINO, Ralph B\";i:2;s:17:\"CAMPBELL, Susan E\";i:3;s:13:\"BRAZIER, Joan\";i:4;s:13:\"BROWN, W. Ted\";i:5;s:18:\"KLEINMAN, Monica E\";i:6;s:14:\"KIERAN, Mark W\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CIRCAZ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:86:\"Impact of Farnesylation Inhibitors on Survival in Hutchinson-Gilford Progeria Syndrome\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
